Patent · US Active

Inhibitors of human immunodeficiency virus replication

US11541055B2 · kind B2 · utility

0Cited by

0References

28Claims

0Family size

Assignee

ViiV Healthcare UK (No.5) Limited · GB

Inventors

Eric P. Gillis · Cheshire, US
Kyle E. Parcella · Wallingford, US
Manoj Patel · Berlin, US

Key dates

Filing date	Oct 22, 2019
Grant date	Jan 3, 2023
Priority date	—
Expiry date	Oct 22, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D403/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.